YS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer...

Stats
Dzisiejszy wolumen	40 694.00
Średni wolumen	176 429
Kapitalizacja rynkowa	180.79M
EPS	$0 ( 2024-04-19 )
Następna data zysków	( $-0.0900 ) 2024-08-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.710
ATR14	$0.0100 (1.04%)

Wolumen Korelacja

Długi: -0.38 (neutral)

Krótki: -0.94 (very strong negative)

Signal:(39.151) Neutral

YS Biopharma Co., Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YS Biopharma Co., Ltd. Korelacja - Waluta/Towar

-0.02
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.02
( neutral )

YS Biopharma Co., Ltd. Finanse

Annual	2023
Przychody:	$687.20M
Zysk brutto:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2023
Przychody:	$687.20M
Zysk brutto:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2022
Przychody:	$502.95M
Zysk brutto:	$385.88M (76.72 %)
EPS:	$-1.150

Financial Reports:

No articles found.

YS Biopharma Co., Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.